Invokana Sales Decline as Lawsuits Increase
Slowly, Type 2 diabetics and their families are becoming more aware of the dangers of SGLT2 inhibitors like Invokana. Recently, Johnson & Johnson, the manufacturer of Invokana released their 2017 First-Quarter Results. U.S. sales of Invokana fell by $50 million, which is almost 20%.
Dangers of Invokana
Invokana is the brand name of the drug canagliflozin, which is a sodium glucose cotransporter-2 (SGLT2) inhibitor. This class of Type 2 diabetes drugs lowers blood sugar by causing the kidneys to remove sugar from the body via urine. This prevents sugar from being reabsorbed into the blood.
On May 15, 2015, the United States Food and Drug Administration (FDA) issued a safety communication regarding SGLT2 inhibitors, including Invokana. These drugs may lead to diabetic ketoacidosis (DKA). DKA happens when the body starts using fats as fuel instead of sugar or glucose. Insulin aids the body in using sugar as fuel, but when a person has diabetes the body cannot use sugar for fuel. Instead, it uses fat. When the fat is brown down, it causes the body to produce acidic chemicals, called ketones. Therefore, ketones build up and poison the body. This build up can cause organs to malfunction
DKA is a dangerous complication of diabetes. Doctors hospitalize around 14% of diabetics because of it. This illness can lead to coma and death. Additionally, researchers linked 16% of all diabetes-related deaths to this side effect.
We are litigating these cases right now and have over 40 cases pending in Philadelphia alone. All of the pending cases were filed on behalf of individuals who allegedly developed diabetic ketoacidosis, kidney damage and other serious complications due to treatment with Invokana. The Michael Brady Lynch Firm has decades of experience going against large pharmaceutical companies and winning multi-million dollar judgments.
You deserve compensation. It can never replace what you have lost, but it can help you recover medical expenses, lost wages and the loss of an ability to work. The consultation is completely free, and you are under zero obligation. We are available 24/7 to take your call.